The US Food and Drug Administration (FDA) has approved Anbogen Therapeutics’ investigational new drug (IND) application for ...

Importers can now apply, track, and receive approval for their drug consignments via an integrated digital portal, ...

Health Canada is supposed to issue rulings on new generics – which are copies of branded drugs whose patents have expired – ...

Gireesh Babu, New Delhi Tuesday, August 5, 2025, 08:00 Hrs [IST] ...

The IND application of IBI3032 was accepted by China’s National Medical Products Administration (NMPA) and approved by the U.S. Food and Drug Administration (FDA). A multi-regional Phase 1 clinical ...

SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the ...

Pharmaceutical company Novartis is suing the Oregon Board of Pharmacy to stop a new state law that would expand how safety-net providers can get discounted prescription drugs. The dispute centers on ...

The FDA is expected to decide on treatments for acromegaly, edema, HSCT-associated thrombotic microangiopathy, multiple sclerosis, and spinal muscular atrophy.

Researchers at the University of Bath have developed a new technology that—for many patients—could make injections a thing of ...

The FDA approved an investigational new drug application for ABT-301, clearing the way for a new clinical trial in metastatic ...

Double-digit prescription gains for its commercial drugs, major coverage wins, and the early launch of a new migraine therapy were the most significant highlights. Despite substantial progress, the ...

A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the works, but any such program ...